TY - JOUR T1 - Functional analysis of <em>TLK2</em> variants and their proximal interactomes implicates impaired kinase activity and chromatin maintenance defects in their pathogenesis JF - Journal of Medical Genetics JO - J Med Genet SP - 170 LP - 179 DO - 10.1136/jmedgenet-2020-107281 VL - 59 IS - 2 AU - Lisa Pavinato AU - Marina Villamor-Payà AU - Maria Sanchiz-Calvo AU - Cristina Andreoli AU - Marina Gay AU - Marta Vilaseca AU - Gianluca Arauz-Garofalo AU - Andrea Ciolfi AU - Alessandro Bruselles AU - Tommaso Pippucci AU - Valentina Prota AU - Diana Carli AU - Elisa Giorgio AU - Francesca Clementina Radio AU - Vincenzo Antona AU - Mario Giuffrè AU - Kara Ranguin AU - Cindy Colson AU - Silvia De Rubeis AU - Paola Dimartino AU - Joseph D Buxbaum AU - Giovanni Battista Ferrero AU - Marco Tartaglia AU - Simone Martinelli AU - Travis H Stracker AU - Alfredo Brusco Y1 - 2022/02/01 UR - http://jmg.bmj.com/content/59/2/170.abstract N2 - Introduction The Tousled-like kinases 1 and 2 (TLK1 and TLK2) are involved in many fundamental processes, including DNA replication, cell cycle checkpoint recovery and chromatin remodelling. Mutations in TLK2 were recently associated with ‘Mental Retardation Autosomal Dominant 57’ (MRD57, MIM# 618050), a neurodevelopmental disorder characterised by a highly variable phenotype, including mild-to-moderate intellectual disability, behavioural abnormalities, facial dysmorphisms, microcephaly, epilepsy and skeletal anomalies.Methods We re-evaluate whole exome sequencing and array-CGH data from a large cohort of patients affected by neurodevelopmental disorders. Using spatial proteomics (BioID) and single-cell gel electrophoresis, we investigated the proximity interaction landscape of TLK2 and analysed the effects of p.(Asp551Gly) and a previously reported missense variant (c.1850C&gt;T; p.(Ser617Leu)) on TLK2 interactions, localisation and activity.Results We identified three new unrelated MRD57 families. Two were sporadic and caused by a missense change (c.1652A&gt;G; p.(Asp551Gly)) or a 39 kb deletion encompassing TLK2, and one was familial with three affected siblings who inherited a nonsense change from an affected mother (c.1423G&gt;T; p.(Glu475Ter)). The clinical phenotypes were consistent with those of previously reported cases. The tested mutations strongly impaired TLK2 kinase activity. Proximal interactions between TLK2 and other factors implicated in neurological disorders, including CHD7, CHD8, BRD4 and NACC1, were identified. Finally, we demonstrated a more relaxed chromatin state in lymphoblastoid cells harbouring the p.(Asp551Gly) variant compared with control cells, conferring susceptibility to DNA damage.Conclusion Our study identified novel TLK2 pathogenic variants, confirming and further expanding the MRD57-related phenotype. The molecular characterisation of missense variants increases our knowledge about TLK2 function and provides new insights into its role in neurodevelopmental disorders.Data are available in a public, open access repository or included in the article or uploaded as supplementary information. ER -